JP Stock MarketDetailed Quotes

4502 Takeda Pharmaceutical

Watchlist
  • 4206.0
  • +14.0+0.33%
20min DelayNoon Break Jul 2 11:22 JST
6.60TMarket Cap46.14P/E (Static)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
5.87%4.26T
9.91%1.05T
1.33%1.11T
4.07%1.04T
8.86%1.06T
12.85%4.03T
9.49%956.16B
21.66%1.1T
18.64%1T
2.41%972.47B
Operating revenue
5.87%4.26T
9.91%1.05T
1.33%1.11T
4.07%1.04T
8.86%1.06T
12.85%4.03T
9.49%956.16B
21.66%1.1T
18.64%1T
2.41%972.47B
Cost of revenue
14.68%1.43T
23.48%382.5B
12.95%379.48B
12.49%343.58B
9.64%321.11B
12.40%1.24T
0.45%309.77B
19.39%335.97B
10.75%305.45B
21.39%292.88B
Gross profit
1.93%2.84T
3.40%668.37B
-3.80%731.71B
0.38%699.51B
8.52%737.5B
13.05%2.78T
14.42%646.38B
22.70%760.58B
22.47%696.86B
-4.06%679.58B
Operating expense
12.92%2.53T
15.85%582.61B
8.43%665.29B
26.40%748.85B
7.54%568.93B
15.55%2.24T
0.17%502.91B
21.89%613.59B
25.62%592.43B
15.07%529.07B
Selling and administrative expenses
5.67%1.05T
11.95%285.23B
1.99%267.52B
1.70%252.95B
7.19%248.11B
12.52%997.31B
14.04%254.8B
13.51%262.3B
17.32%248.73B
5.29%231.48B
Research and development costs
15.25%729.92B
21.69%195.86B
7.30%187.38B
19.33%183.95B
13.32%162.74B
20.38%633.33B
12.06%160.94B
36.03%174.63B
17.13%154.15B
17.25%143.61B
Depreciation amortization depletion
20.22%652.12B
8.92%145.11B
1.30%137.34B
68.75%240.24B
-1.41%129.42B
14.70%542.44B
-10.76%133.22B
14.81%135.58B
38.59%142.37B
27.67%131.28B
-Depreciation and amortization
20.22%652.12B
8.92%145.11B
1.30%137.34B
68.75%240.24B
-1.41%129.42B
14.70%542.44B
-10.76%133.22B
14.81%135.58B
38.59%142.37B
27.67%131.28B
Other operating expenses
40.70%91.32B
5.35%-43.59B
77.81%73.05B
51.99%71.71B
26.22%28.66B
26.09%64.91B
-222.36%-46.06B
58.86%41.08B
86.76%47.18B
55.08%22.7B
Operating profit
-43.18%309.9B
-40.23%85.76B
-54.82%66.42B
-147.25%-49.34B
12.00%168.57B
3.83%545.42B
128.26%143.48B
26.19%146.99B
7.20%104.44B
-39.44%150.52B
Net non-operating interest income /expenses
-13.84%-140.46B
73.14%-13.9B
-17.62%-44.78B
-24.71%-48.66B
-707.04%-33.12B
0.07%-123.39B
-126.11%-51.75B
10.55%-38.07B
-18.92%-39.02B
121.64%5.46B
Non-operating interest income
105.03%11.29B
29.85%-34.81B
-47.72%21.79B
-36.69%9.36B
-56.58%26.46B
19.97%5.51B
-29.37%-49.62B
905.52%41.68B
115.36%14.78B
32.88%60.93B
Non-operating interest expense
2.19%119.54B
-442.57%-53.13B
-16.53%66.57B
7.84%58.02B
7.40%59.58B
-4.46%116.97B
53.61%-9.79B
70.75%79.75B
35.61%53.8B
-21.95%55.47B
Total other finance cost
170.31%32.22B
----
----
----
----
111.50%11.92B
----
----
----
----
Other net income /expenses
-148.47%-116.65B
-172.47%-119.38B
2,342.44%39.62B
333.03%2.03B
15.90%-418M
52.71%-46.95B
53.40%-43.81B
-2.14%-1.77B
72.57%-869M
-39.22%-497M
Gain on sale of security
-241.82%-9.13B
----
----
----
----
126.60%6.44B
----
----
----
----
Special income /charges
-69.69%-113.99B
----
----
----
----
1.47%-67.17B
----
----
----
----
-Less:Restructuring and mergern&acquisition
61.51%102.12B
----
----
----
----
-12.96%63.23B
----
----
----
----
-Less:Other special charges
122.71%18.16B
----
----
----
----
120.50%8.15B
----
----
----
----
-Less:Write off
-64.10%1.69B
----
----
----
----
--4.69B
----
----
----
----
-Gain on sale of business
15.04%7.83B
----
----
----
----
-2.98%6.81B
----
----
----
----
-Gain on sale of property,plant,equipment
-93.12%144M
----
----
----
----
82.40%2.09B
----
----
----
----
Income before tax
-85.93%52.79B
-199.18%-47.52B
-42.83%61.26B
-248.69%-95.98B
-13.15%135.03B
23.97%375.09B
188.65%47.92B
48.43%107.15B
5.05%64.55B
-30.27%155.47B
Income tax
-257.46%-91.41B
-365.38%-44.53B
-270.92%-44.5B
-1,804.26%-48.01B
-9.56%45.63B
-19.82%58.05B
139.32%16.78B
-183.46%-12B
-81.77%2.82B
-40.82%50.45B
Net income
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.71%31.14B
106.07%119.15B
34.22%61.73B
-23.75%105.02B
Net income continuous operations
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.72%31.14B
106.07%119.15B
34.21%61.73B
-23.75%105.02B
Noncontrolling interests
519.05%130M
1,100.00%24M
59.09%35M
690.00%59M
57.14%11M
-80.37%21M
111.76%2M
-56.86%22M
-132.26%-10M
-83.72%7M
Net income attributable to the company
-54.56%144.07B
-109.69%-3.02B
-11.25%105.72B
-177.79%-48.03B
-14.87%89.4B
37.80%317.02B
374.12%31.13B
106.21%119.13B
34.33%61.74B
-23.73%105.01B
Net income attributable to common stockholders
-54.56%144.07B
-109.69%-3.02B
-11.25%105.72B
-177.79%-48.03B
-14.87%89.4B
37.80%317.02B
374.12%31.13B
106.21%119.13B
34.33%61.74B
-23.73%105.01B
Diluted earnings per share
-54.92%92.09
-110.07%-2.01
-11.80%67.59
-177.14%-30.68
-15.35%57.51
38.84%204.29
387.34%19.97
107.61%76.63
36.01%39.77
-22.76%67.94
Basic earnings per share
-54.86%91.16
-110.42%-2.01
-11.84%66.88
-177.71%-30.68
-15.45%57.12
38.44%201.94
369.41%19.29
106.82%75.86
35.76%39.48
-22.74%67.56
Dividend per share
4.44%188
4.44%94
--0
4.44%94
--0
0.00%180
0.00%90
--0
0.00%90
--0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue 5.87%4.26T9.91%1.05T1.33%1.11T4.07%1.04T8.86%1.06T12.85%4.03T9.49%956.16B21.66%1.1T18.64%1T2.41%972.47B
Operating revenue 5.87%4.26T9.91%1.05T1.33%1.11T4.07%1.04T8.86%1.06T12.85%4.03T9.49%956.16B21.66%1.1T18.64%1T2.41%972.47B
Cost of revenue 14.68%1.43T23.48%382.5B12.95%379.48B12.49%343.58B9.64%321.11B12.40%1.24T0.45%309.77B19.39%335.97B10.75%305.45B21.39%292.88B
Gross profit 1.93%2.84T3.40%668.37B-3.80%731.71B0.38%699.51B8.52%737.5B13.05%2.78T14.42%646.38B22.70%760.58B22.47%696.86B-4.06%679.58B
Operating expense 12.92%2.53T15.85%582.61B8.43%665.29B26.40%748.85B7.54%568.93B15.55%2.24T0.17%502.91B21.89%613.59B25.62%592.43B15.07%529.07B
Selling and administrative expenses 5.67%1.05T11.95%285.23B1.99%267.52B1.70%252.95B7.19%248.11B12.52%997.31B14.04%254.8B13.51%262.3B17.32%248.73B5.29%231.48B
Research and development costs 15.25%729.92B21.69%195.86B7.30%187.38B19.33%183.95B13.32%162.74B20.38%633.33B12.06%160.94B36.03%174.63B17.13%154.15B17.25%143.61B
Depreciation amortization depletion 20.22%652.12B8.92%145.11B1.30%137.34B68.75%240.24B-1.41%129.42B14.70%542.44B-10.76%133.22B14.81%135.58B38.59%142.37B27.67%131.28B
-Depreciation and amortization 20.22%652.12B8.92%145.11B1.30%137.34B68.75%240.24B-1.41%129.42B14.70%542.44B-10.76%133.22B14.81%135.58B38.59%142.37B27.67%131.28B
Other operating expenses 40.70%91.32B5.35%-43.59B77.81%73.05B51.99%71.71B26.22%28.66B26.09%64.91B-222.36%-46.06B58.86%41.08B86.76%47.18B55.08%22.7B
Operating profit -43.18%309.9B-40.23%85.76B-54.82%66.42B-147.25%-49.34B12.00%168.57B3.83%545.42B128.26%143.48B26.19%146.99B7.20%104.44B-39.44%150.52B
Net non-operating interest income /expenses -13.84%-140.46B73.14%-13.9B-17.62%-44.78B-24.71%-48.66B-707.04%-33.12B0.07%-123.39B-126.11%-51.75B10.55%-38.07B-18.92%-39.02B121.64%5.46B
Non-operating interest income 105.03%11.29B29.85%-34.81B-47.72%21.79B-36.69%9.36B-56.58%26.46B19.97%5.51B-29.37%-49.62B905.52%41.68B115.36%14.78B32.88%60.93B
Non-operating interest expense 2.19%119.54B-442.57%-53.13B-16.53%66.57B7.84%58.02B7.40%59.58B-4.46%116.97B53.61%-9.79B70.75%79.75B35.61%53.8B-21.95%55.47B
Total other finance cost 170.31%32.22B----------------111.50%11.92B----------------
Other net income /expenses -148.47%-116.65B-172.47%-119.38B2,342.44%39.62B333.03%2.03B15.90%-418M52.71%-46.95B53.40%-43.81B-2.14%-1.77B72.57%-869M-39.22%-497M
Gain on sale of security -241.82%-9.13B----------------126.60%6.44B----------------
Special income /charges -69.69%-113.99B----------------1.47%-67.17B----------------
-Less:Restructuring and mergern&acquisition 61.51%102.12B-----------------12.96%63.23B----------------
-Less:Other special charges 122.71%18.16B----------------120.50%8.15B----------------
-Less:Write off -64.10%1.69B------------------4.69B----------------
-Gain on sale of business 15.04%7.83B-----------------2.98%6.81B----------------
-Gain on sale of property,plant,equipment -93.12%144M----------------82.40%2.09B----------------
Income before tax -85.93%52.79B-199.18%-47.52B-42.83%61.26B-248.69%-95.98B-13.15%135.03B23.97%375.09B188.65%47.92B48.43%107.15B5.05%64.55B-30.27%155.47B
Income tax -257.46%-91.41B-365.38%-44.53B-270.92%-44.5B-1,804.26%-48.01B-9.56%45.63B-19.82%58.05B139.32%16.78B-183.46%-12B-81.77%2.82B-40.82%50.45B
Net income -54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.71%31.14B106.07%119.15B34.22%61.73B-23.75%105.02B
Net income continuous operations -54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.72%31.14B106.07%119.15B34.21%61.73B-23.75%105.02B
Noncontrolling interests 519.05%130M1,100.00%24M59.09%35M690.00%59M57.14%11M-80.37%21M111.76%2M-56.86%22M-132.26%-10M-83.72%7M
Net income attributable to the company -54.56%144.07B-109.69%-3.02B-11.25%105.72B-177.79%-48.03B-14.87%89.4B37.80%317.02B374.12%31.13B106.21%119.13B34.33%61.74B-23.73%105.01B
Net income attributable to common stockholders -54.56%144.07B-109.69%-3.02B-11.25%105.72B-177.79%-48.03B-14.87%89.4B37.80%317.02B374.12%31.13B106.21%119.13B34.33%61.74B-23.73%105.01B
Diluted earnings per share -54.92%92.09-110.07%-2.01-11.80%67.59-177.14%-30.68-15.35%57.5138.84%204.29387.34%19.97107.61%76.6336.01%39.77-22.76%67.94
Basic earnings per share -54.86%91.16-110.42%-2.01-11.84%66.88-177.71%-30.68-15.45%57.1238.44%201.94369.41%19.29106.82%75.8635.76%39.48-22.74%67.56
Dividend per share 4.44%1884.44%94--04.44%94--00.00%1800.00%90--00.00%90--0
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg